Back to Search Start Over

Lead-free iron-doped Cs 3 Bi 2 Br 9 perovskite with tunable properties.

Authors :
Htun T
Elattar A
Elbohy H
Tsutsumi K
Horigane K
Nakano C
Gu X
Suzuki H
Nishikawa T
Kyaw AKK
Hayashi Y
Source :
RSC advances [RSC Adv] 2024 Jul 23; Vol. 14 (32), pp. 23177-23183. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).
Publication Year :
2024

Abstract

Perovskite based on cesium bismuth bromide offers a compelling, non-toxic alternative to lead-containing counterparts in optoelectronic applications. However, its widespread usage is hindered by its wide bandgap. This study investigates a significant bandgap tunability achieved by introducing Fe doping into the inorganic, lead-free, non-toxic, and stable Cs <subscript>3</subscript> Bi <subscript>2</subscript> Br <subscript>9</subscript> perovskite at varying concentrations. The materials were synthesized using a facile method, with the aim of tuning the optoelectronic properties of the perovskite materials. Characterization through techniques such as X-ray diffraction, Raman spectroscopy, X-ray photoelectron spectroscopy, energy dispersive spectroscopy (EDS), and UV-vis spectroscopy was conducted to elucidate the transformation mechanism of the doping materials. The substitution process results in a significant change in the bandgap energy, transforming from the pristine Cs <subscript>3</subscript> Bi <subscript>2</subscript> Br <subscript>9</subscript> with a bandgap of 2.54 eV to 1.78 eV upon 70% Fe doping. The addition of 50% Fe in Cs <subscript>3</subscript> Bi <subscript>2</subscript> Br <subscript>9</subscript> leads to the formation of the orthorhombic structure in Cs <subscript>2</subscript> (Bi,Fe)Br <subscript>5</subscript> perovskite, while complete Fe alloying at 100% results in the phase formation of CsFeBr <subscript>4</subscript> perovskite. Our findings on regulation of bandgap energy and crystal structure through B site substitution hold significant promise for applications in optoelectronics.<br />Competing Interests: The authors declare that they have no conflict of interest.<br /> (This journal is © The Royal Society of Chemistry.)

Details

Language :
English
ISSN :
2046-2069
Volume :
14
Issue :
32
Database :
MEDLINE
Journal :
RSC advances
Publication Type :
Academic Journal
Accession number :
39045399
Full Text :
https://doi.org/10.1039/d4ra04062g